Bio-Rad Q4 Revenues Climb 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said after the close of the market on Tuesday that fourth-quarter revenues improved 4 percent year over year as the firm beat the average analyst estimate on the top and bottom lines.

The company took in $573.8 million in revenues for the three months ended Dec. 31, 2012, up from $550.2 million a year ago, easily surpassing the average analyst estimate of $558.7 million.

On a currency-neutral basis, revenues were up 6 percent year over year, Bio-Rad said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.